Nasal Therapeutics to Enter Migraine Headache Market With New Migraine Relief Homeopathic Nasal Spray
LOS ANGELES, Dec. 4 /PRNewswire/ -- Nasal Therapeutics, Inc. announced
today plans to enter the over-the-counter market with a new migraine relief
homeopathic nasal spray. The nasal spray is scheduled to hit the shelves in
the spring of 2008. Nasal Therapeutics, Inc., a subsidiary of Hensley
Group, will launch a line of homeopathic nasal sprays over the next year
which will include remedies for allergy, cold and flu.
"There are approximately thirty million migraine sufferers in the
United States alone", commented Dr. Charles Hensley, Inventor of Zicam Cold
Remedy and Chairman of Hensley Group. "Migraine attacks are severe, come on
suddenly and are often debilitating. Nasal sprays are the delivery system
of choice when it comes to conditions that require rapid relief as they
work much faster than oral formulations."
"The development of the technology behind the new migraine product was
actually quite serendipitous", added Hensley. "While working with
intracellular mediators involved in the development of common colds, our
scientists discovered that these same compounds are putative causative
factors in the genesis and maintenance of migraine attacks. Since they were
already developing nasal delivery compounds to address this therapeutic
target, it was a natural to pursue a therapy for migraine attack," he
continued.
About Nasal Therapeutics
Nasal Therapeutics develops and markets homeopathic nasal sprays for
such conditions as common cold, influenza, allergy and migraine. The
company is based on the concept that nasal delivery is the fastest, most
effective way to deliver over-the-counter medicines to the site of
therapeutic action. Nasal therapeutics was incorporated in 2007 and is in
the process of closing its first round of financing.
For further information please contact:
Investor Relations at ir@nasal-theraeutics.com
About Hensley Group
Hensley Group controls a diverse group of subsidiary companies engaged
in Pharmaceuticals, Biotechnology, Cosmetics, Consulting, Media Marketing
and Entertainment and has offices in Los Angeles, Hong Kong, Shanghai and
Tokyo.
SOURCE Nasal Therapeutics, Inc. |
